TMCI
TMCI
NASDAQ · Health Care

Treace Medical Concepts Inc

$1.34
+0.14 (+11.67%)
As of Mar 31, 10:10 PM ET ·
Financial Highlights (FY 2026)
Revenue
227.81M
Net Income
-63,199,588
Gross Margin
79.8%
Profit Margin
-27.7%
Rev Growth
+14.5%
D/E Ratio
0.64
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 79.8% 79.8% 54.2% 54.2%
Operating Margin -26.7% -24.1% 18.2% 18.5%
Profit Margin -27.7% -26.4% 13.5% 12.7%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 227.81M 199.02M 42.92M 46.18M
Gross Profit 181.82M 158.83M 23.26M 25.03M
Operating Income -60,939,877 -47,912,893 7.80M 8.54M
Net Income -63,199,588 -49,689,551 5.79M 5.86M
Gross Margin 79.8% 79.8% 54.2% 54.2%
Operating Margin -26.7% -24.1% 18.2% 18.5%
Profit Margin -27.7% -26.4% 13.5% 12.7%
Rev Growth +14.5% +14.5% +24.4% -6.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 16.08M 16.08M 8.48M 7.21M
Total Equity 25.26M 25.26M 83.95M 82.42M
D/E Ratio 0.64 0.64 0.10 0.09
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -49,097,256 -40,746,390 10.44M 11.89M
Free Cash Flow 4.81M 4.94M